On 17 January 2016, a healthy man was declared brain-dead after receiving an experimental drug in a first-in-human trial in France. Four of five other subjects receiving the same dose have serious, ongoing neurological complications. Investigations into the trial described many troubling safety practices, such as steep increases in dose levels delivered to sequential subjects without sufficient delays to check for safety. In the wake of the tragedies, the French medicines safety agency (ANSM) ordered an examination of the information that the drug developer, Bial, based in Trofa, Portugal, had supplied to ethics committees and potential researchers before the trial. The report notes that the 63-page Investigator Brochure describing the trial included fewer than two pages of evidence that the drug had the desired pharmacological activity. It identified only two studies presented as evidence for efficacy, both problematic. A lack of emphasis on evidence for the efficacy of drug candidates is all too common in decisions about whether an experimental medicine can be tested in humans. There is a need to call for infrastructure, resources and better methods to rigorously evaluate the clinical promise of new interventions before testing them on humans for the first time, to ensure safety from bogus medicines.
DelveInsight Blog

Where Women Healthcare Stands
Mar 11, 2019
Technology has made an impact on every field. And Healthcare is no exception. Advances in medical technology have pro...

Cholera vaccine delivered; Rice-inspired b...
Nov 07, 2018
Cholera vaccine delivered through a cup of rice water Vaccinations against prevalent pathogens could be ingested as o...

Snippet
Aug 29, 2018
National health authorities, U.K.'s NICE determines Gilead's cancer cell therapy exorbitant The National Institute fo...
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU ...
Patent protection and expiration is one of the hot topics in the healthcare industry. P...
What are the Top 9 Most Common Food Allergies and How Pharma Companies are Ta...
Food Allergies is a major concern for a wide spectrum of populations globally. Accordin...
Evaluating the Top Players in the Global Bone Densitometers Market
Bone densitometers are the diagnostic systems with an enhanced X-ray technology known a...
Mapping the Biggest Pharmaceutical Companies by Continents
Today, the most important factor affecting the world’s economy is the Global Pharmaceut...
Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Develop...
It's no longer startling to learn that the best-performing surgeon at a hospital isn't ...
RECENT ARTICLES